Kyorin rejects Sawai's latest merger overture
This article was originally published in Scrip
Executive Summary
Japan's Kyorin Holdings has again brushed off advances from its suitor Sawai Pharmaceutical, saying that the latest merger proposal from the smaller generics firm would not be in its best interests.